U.S. Healthcare Services Stock News

Savara (SVRA) is back in focus after the FDA accepted the resubmitted biologics license application for Molbreevi, supported by positive long term phase III data and paired with expanded European patent protection. See our latest analysis for Savara. Despite a small pullback in the latest session, with the share price down 3.25% to US$5.65, Savara has seen momentum build over a longer horizon. This is reflected in a 90 day share price return of 14.37% and a 1 year total shareholder return of...

X-Energy has joined high profile nuclear headlines this year, but with the stock down 43.7% year to date and both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples pointing to a premium, the price now raises questions about how much of the story is already reflected in the share price. The share price has fallen 43.7% year to date, which means investors are being asked to reassess what they are willing to pay for X-Energy's future cash flows. Participation in U.S...

Datadog recently lagged the broader market over the past week as investors responded to shifting sentiment ahead of its next earnings release. Despite forecasts for strong year-over-year gains in earnings and revenue, the company’s premium valuation versus peers is drawing closer scrutiny from analysts and investors. We’ll now examine how anticipation around Datadog’s upcoming earnings release, alongside elevated valuation, may influence the company’s existing investment narrative. The best...

Kemper Corporation has confirmed that Matthew A. Hunton left his role as Executive Vice President and President of Kemper Auto, and has appointed former Bristol West Insurance president Eric Kappler as Executive Vice President and President of its unified property and casualty business. This shift consolidates leadership over Kemper’s auto and broader P&C operations under a single executive, potentially reshaping how the company manages its core insurance lines and claims functions. We’ll...

On July 13, 2026, CoreCivic, Inc. announced that it had given irrevocable notice to redeem in full its remaining $238,468,000 of 4.750% senior notes due 2027 on August 12, 2026, at par plus a make-whole premium and accrued interest, using cash on hand. This early repayment accelerates CoreCivic’s debt reduction timetable and highlights the company’s current liquidity position and willingness to lower future interest obligations. We’ll now examine how CoreCivic’s decision to fully redeem its...

AGNC Investment (AGNC) reported second quarter 2026 earnings that shifted from a net loss a year ago to net income of US$654 million, a key update for income focused mortgage REIT investors. See our latest analysis for AGNC Investment. AGNC Investment's recent earnings release comes after a mixed price stretch, with the share price down 5.3% over the past week but showing a 3.3% share price gain over the past month. The 1 year total shareholder return of 28.4% and 3 year total shareholder...

Whirlpool (WHR) is back in focus after multiple research firms cut earnings projections and flagged softer revenue expectations ahead of the next quarterly report, citing higher interest costs and plant closures as key pressure points. See our latest analysis for Whirlpool. At a share price of US$37.14, Whirlpool has seen its 90 day share price return fall 31.48% and its 1 year total shareholder return decline 61.31%. This suggests selling pressure has built as earnings expectations and plant...

Nutex Health (NUTX) has drawn fresh attention after amending its agreement with HaloMD to a pay as you go model, aligning with No Surprises Act rules as investors watch upcoming quarterly results. See our latest analysis for Nutex Health. Nutex Health’s recent shift to a pay as you go model with HaloMD comes as the stock experiences mixed momentum, with the share price down 6.57% over one day and 10.68% over seven days, but up 4.69% over 30 days and 43.83% over 90 days, alongside a 69.23% 1...

JPMorgan Chase CEO Jamie Dimon recently backed Space Exploration Technologies' push into orbital AI data centers, describing Starlink as an "extraordinary product" while flagging major technical and valuation risks. SpaceX also completed a satellite repair mission launch, highlighting its entry into space infrastructure and on orbit services beyond its core launch business. For investors watching Space Exploration Technologies, ticker NasdaqGS:SPCX, these developments arrive while the stock...

In the recent past, analysts projected that Ecolab’s June 2026 quarter earnings per share would be US$2.08, up 10.1% year over year, on revenue of US$4.40 billion, a 9.3% increase. A slightly positive Earnings ESP of 0.20% has drawn attention, as it hints at a possible earnings beat and rising confidence in Ecolab’s near-term performance. With analysts expecting year-over-year earnings growth of 10.1%, we’ll assess how this optimism interacts with Ecolab’s existing investment narrative. The...

Palomar Holdings stock trades with an earnings multiple profile that screens as overvalued, yet a 115.8% gain over the past 3 years and a mid range valuation score leave the overall picture less clear cut for long term investors. Over the past 3 years, Palomar Holdings has returned 115.8%, which means anyone who stayed invested through that period has already seen a substantial payoff that can limit future upside if expectations are too high. The key support for the valuation may be...

General Motors (GM) stock is in focus after the company completed a large share repurchase program and reaffirmed its quarterly dividend, moves that directly affect share count and ongoing cash returns to investors. See our latest analysis for General Motors. The recent buyback completion, dividend affirmation and upgraded 2026 guidance have coincided with a 1-year total shareholder return of 56.0%, while the 3-year total shareholder return of 121.19% points to strong longer term momentum...

Why Mercury Systems Stock Is Back in Focus Mercury Systems (MRCY) is attracting attention after very large earnings surprises in recent quarters, capped by earnings of $0.27 per share versus an estimate of $0.06 last quarter. See our latest analysis for Mercury Systems. At a share price of $98.92, Mercury Systems has given investors a 90 day share price return of 25.36%, while the 1 year total shareholder return of 86.96% highlights stronger momentum over the longer stretch, despite a 30 day...

Artificial intelligence and cloud computing are drawing huge attention after Alphabet’s Q2 2026 report put AI spending, Google Cloud’s rapid 64% YoY growth estimate, and the sustainability of capital expenditures in the spotlight. At the same time, new lower cost Gemini models, questions about AI talent departures, and resilient digital ad revenues from Search and YouTube are reshaping expectations. For investors, this news is a reminder that heavy AI and cloud investment can help or hurt,...

The latest flare up in the US Iran conflict, a 3.5% move in Brent crude to $94.22 per barrel, and threats to key shipping routes in the Strait of Hormuz have pushed energy risks and opportunities back into focus. When supply routes look fragile and regional infrastructure is at risk, some oil and gas producers can see fresh interest while others face higher costs and operational pressure. This article looks at 3 large, listed stocks from our Energy Sector: Oil & Gas Producers screener that...

Piedmont Realty Trust (PDM) has drawn investor attention after recent share price moves, with the stock now around $9.57. That shift, along with its latest financial figures, is prompting a closer look at valuation. See our latest analysis for Piedmont Realty Trust. Recent moves in Piedmont Realty Trust’s share price, including a 6.22% 1 month share price return and an 18.59% 3 month share price return, sit alongside a 26.09% 1 year total shareholder return and a 44.01% 3 year total...

Retirees could see bigger Social Security checks if policymakers adopt the R-CPI-E inflation measure, and that potential shift has put healthcare stocks under a brighter spotlight. Larger annual COLAs would give older consumers more room to spend on medical care, treatments, and related services, while also raising questions about long term government costs. This article looks at how that policy debate ties into a curated Healthcare Sector Stocks screener, and reveals 3 stocks that appear...

Eisai and Biogen recently gained US FDA approval for LEQEMBI IQLIK, an at-home subcutaneous autoinjector for early Alzheimer’s treatment initiation and maintenance, while Biogen also reported Phase 2 CELIA data showing tau reduction and slowed clinical decline with its investigational therapy diranersen. Together, these advances position Biogen as a key player in both amyloid- and tau-targeting Alzheimer’s approaches, potentially reshaping treatment access and disease management...

Qualys (QLYS) is back in focus after the company scheduled its second quarter 2026 earnings release for after the close on August 4, along with a conference call and live webcast. See our latest analysis for Qualys. Qualys shares, which last closed at US$140.23, have pulled back over the past week with a 7 day share price return that declined 11.98%. This comes after a 30 day share price return of 29.23% and a 90 day share price return of 66.86%, while the 1 year total shareholder return is...

VinFast Auto (NasdaqGS:VFS) is rolling out an integrated mobility ecosystem aimed at lowering barriers to electric vehicle adoption for global consumers. The company is focusing on aggressive leasing offers, competitive ownership packages, and comprehensive warranty programs to widen access to its EVs. VinFast is also emphasizing broad compatibility with public charging networks, targeting easier daily use of its vehicles for American drivers. This approach is designed to position VinFast as...

Organon stock has quietly turned into a strong performer in 2026, with the sharp year to date gain sitting alongside valuation checks that still suggest the shares screen as cheap rather than stretched. Year to date, Organon is up 86.7%, which puts recent momentum front and center for anyone asking whether the current price already reflects the recovery story. The key swing factor for what Organon is worth is how consistently it can convert revenue into cash that supports its balance sheet,...

With central banks watching inflation, energy markets reacting to Middle East tensions, and governments reassessing security priorities, many investors are looking more closely at resilient, mission critical sectors. The Aerospace And Defense screener focuses on companies that manufacture or provide services to these industries, which sit at the intersection of geopolitics, trade flows, and long term public spending plans. This article highlights 3 stocks from the screener that stand out on...

Why healthcare students are putting DraftKings stock back in focus A new report on healthcare student finances has drawn attention to DraftKings (DKNG), as a meaningful share of nursing students now use betting and prediction platforms to help cover tuition costs. This unexpected link between education funding and gaming platforms has put DraftKings under a different kind of spotlight, raising questions about how its products are used and how that context might shape how you think about the...

EQT (EQT) has just posted Q2 2026 results with total revenue of US$1.8 billion and basic EPS of US$0.34, alongside trailing twelve month revenue of US$9.3 billion and EPS of US$4.34 that reflect the broader earnings picture over the last year. Over recent quarters, the company has seen revenue shift from US$1.8 billion in Q2 2025 to US$1.8 billion in Q2 2026, while basic EPS moved from US$1.31 to US$0.34, setting a clear reference point against the trailing twelve month totals. Taken together...